FDA approves treatment for 'hairy cell' leukemia
Friday, September 14, 2018 - 15:00
in Health & Medicine
Lumoxiti injection has been approved for certain instances of relapsed or refractory "hairy cell" leukemia, the U.S. Food and Drug Administration said Thursday